Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization

Chih Chan Lee, Jiunn Chang Lin, Wei Lun Hwang, Ying Ju Kuo, Hung Kai Chen, Shyh Kuan Tai, Chun Chi Lin, Muh Hwa Yang*


研究成果: Article同行評審

87 引文 斯高帕斯(Scopus)


A favorable interplay between cancer cells and the tumor microenvironment (TME) facilitates the outgrowth of metastatic tumors. Because of the distinct initiating processes between primary and metastatic tumors, we investigate the differences in tumor-associated macrophages (TAMs) from primary and metastatic cancers. Here we show that dual expression of M1 and M2 markers is noted in TAMs from primary tumors, whereas predominant expression of M2 markers is shown in metastatic TAMs. At metastatic sites, TAMs secrete interleukin-35 (IL-35) to facilitate metastatic colonization through activation of JAK2–STAT6-GATA3 signaling to reverse epithelial–mesenchymal transition (EMT) in cancer cells. In primary tumors, inflammation-induced EMT upregulates IL12Rβ2, a subunit of the IL-35 receptor, in cancer cells to help them respond to IL-35 during metastasis. Neutralization of IL-35 or knockout of IL-35 in macrophages reduces metastatic colonization. These results indicate the distinct TMEs of primary and metastatic tumors and provide potential targets for intercepting metastasis.

期刊Nature Communications
出版狀態Published - 1 12月 2018


深入研究「Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization」主題。共同形成了獨特的指紋。